Literature DB >> 11167473

The haemodynamics of human septic shock.

I M MacKenzie1.   

Abstract

In the time it has taken medicine to develop the techniques to describe the circulatory changes of severe infections, both pattern and process have been profoundly influenced by the use of intravenous fluids, vasopressors, antibiotics, steroids, mechanical ventilation and haemoflltration. Constant features of severe sepsis include a reduction in peripheral vascular tone on both the arterial and venous sides of the circulation, a defect in oxygen utilisation resulting in lactic acidosis, and varying degrees of myocardial dysfunction. These events have a temporal progression, the precise pattern observed depending on the tempo of the infection, the influence of therapeutic manoeuvres, the age and comorbidities of the patient, and the time the observations are made in the course of events. Early sepsis is accompanied by a decrease in systemic vascular resistance and a metabolic acidosis. The clinical picture includes fever, tachycardia, tachypnoea, respiratory alkalosis and an increased cardiac output with warm, dry peripheries and a bounding pulse. Advanced sepsis involves varying degrees of venous and myocardial contractile failure, and is characterised by progressive acidaemia, respiratory failure and marked sympathetic adrenergic activation. In the absence of vigorous fluid resuscitation, the cardiac output is decreased and the patients are cold, clammy peripherally shut down, and frequently confused, obtunded or comatose. In infections with a silent primary focus (predominantly involving Gram-negative organisms), this stage is frequently the first to attract the attention of attending staff. Late sepsis is characterised by profound acidaemia, vascular hypo-responsiveness, multiple organ failure and death.

Entities:  

Mesh:

Year:  2001        PMID: 11167473     DOI: 10.1046/j.1365-2044.2001.01866.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  11 in total

1.  In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia.

Authors:  Maaike J Bruins; Wouter H Lamers; Alfred J Meijer; Peter B Soeters; Nicolaas E P Deutz
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 2.  Critical care in the emergency department: shock and circulatory support.

Authors:  C A Graham; T R J Parke
Journal:  Emerg Med J       Date:  2005-01       Impact factor: 2.740

Review 3.  Sepsis pathophysiology and anesthetic consideration.

Authors:  Koichi Yuki; Naoka Murakami
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2015

4.  The conserved nhaAR operon is drastically divergent between B2 and non-B2 Escherichia coli and is involved in extra-intestinal virulence.

Authors:  Mathilde Lescat; Florence Reibel; Coralie Pintard; Sara Dion; Jérémy Glodt; Cecile Gateau; Adrien Launay; Alice Ledda; Stephane Cruveiller; Stephane Cruvellier; Jérôme Tourret; Olivier Tenaillon
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 5.  Sepsis-associated encephalopathy.

Authors:  Teneille E Gofton; G Bryan Young
Journal:  Nat Rev Neurol       Date:  2012-09-18       Impact factor: 42.937

6.  High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock.

Authors:  Rodrigo Cornejo; Patricio Downey; Ricardo Castro; Carlos Romero; Tomas Regueira; Jorge Vega; Luis Castillo; Max Andresen; Alberto Dougnac; Guillermo Bugedo; Glenn Hernandez
Journal:  Intensive Care Med       Date:  2006-03-21       Impact factor: 17.440

Review 7.  Complement and sepsis-induced heart dysfunction.

Authors:  Fatemeh Fattahi; Peter A Ward
Journal:  Mol Immunol       Date:  2016-12-05       Impact factor: 4.407

8.  Patterns of unexpected in-hospital deaths: a root cause analysis.

Authors:  Lawrence A Lynn; J Paul Curry
Journal:  Patient Saf Surg       Date:  2011-02-11

9.  Hemoadsorption by CytoSorb in septic patients: a case series.

Authors:  Klaus Kogelmann; Dominik Jarczak; Morten Scheller; Matthias Drüner
Journal:  Crit Care       Date:  2017-03-27       Impact factor: 9.097

Review 10.  Sepsis Associated Encephalopathy.

Authors:  Neera Chaudhry; Ashish Kumar Duggal
Journal:  Adv Med       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.